Dominari Holdings Inc. financial data

Symbol
DOMH on Nasdaq
Location
725 Fifth Avenue, 22 Nd Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
Aikido Pharma Inc. (to 12/21/2022), AIkido Pharma Inc. (to 12/21/2022), SPHERIX INC (to 3/13/2020), BIOSPHERICS INC (to 3/21/2001)
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.12K % -47.4%
Debt-to-equity 11.6 % +66.6%
Return On Equity -50.1 % -41.8%
Return On Assets -44.9 % -35.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.28M shares +17.4%
Common Stock, Shares, Outstanding 6.28M shares +18.8%
Entity Public Float 12.1M USD -60.7%
Common Stock, Value, Issued 9K USD 0%
Weighted Average Number of Shares Outstanding, Basic 6.33M shares +18.4%
Weighted Average Number of Shares Outstanding, Diluted 6.33M shares +18.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 4.04M USD +320%
Research and Development Expense 2K USD -94.4%
General and Administrative Expense 27.2M USD +78%
Operating Income (Loss) -14.6M USD +23.6%
Nonoperating Income (Expense) -8.1M USD -96.3%
Net Income (Loss) Attributable to Parent -22.7M USD +2.3%
Earnings Per Share, Basic -3.81 USD/shares +14.8%
Earnings Per Share, Diluted -3.38 USD/shares +24.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.4M USD -22.4%
Marketable Securities, Current 3.77M USD -76.8%
Cash, Cash Equivalents, and Short-term Investments 13K USD
Assets, Current 24.8M USD -29%
Other Long-term Investments 20.9M USD
Property, Plant and Equipment, Net 265K USD -26.6%
Operating Lease, Right-of-Use Asset 3.05M USD -11%
Assets 43.4M USD -31.3%
Employee-related Liabilities, Current 177K USD -86.8%
Liabilities, Current 2.42M USD +40.3%
Operating Lease, Liability, Noncurrent 2.75M USD -12.4%
Liabilities 5.16M USD +6.28%
Retained Earnings (Accumulated Deficit) -225M USD -11.2%
Stockholders' Equity Attributable to Parent 38.3M USD -34.4%
Liabilities and Equity 43.4M USD -31.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.59M USD -115%
Net Cash Provided by (Used in) Financing Activities -939K USD -105%
Net Cash Provided by (Used in) Investing Activities 7.72M USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 6.34M shares +18.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -23.6M USD -566%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.4M USD -22.4%
Deferred Tax Assets, Valuation Allowance 55.9M USD +13.9%
Deferred Tax Assets, Gross 57.2M USD +15.6%
Operating Lease, Liability 3.15M USD -11.2%
Depreciation 26K USD +271%
Payments to Acquire Property, Plant, and Equipment 361K USD
Lessee, Operating Lease, Liability, to be Paid 4.18M USD -15%
Property, Plant and Equipment, Gross 427K USD
Operating Lease, Liability, Current 402K USD -2.19%
Lessee, Operating Lease, Liability, to be Paid, Year Two 685K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 698K USD -6.56%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.03M USD -24.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 685K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 33.1M USD +26.2%
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 766K USD +11.8%
Operating Lease, Payments 187K USD +450%
Additional Paid in Capital 263M USD +1%
Deferred Tax Assets, Net of Valuation Allowance 1.22M USD +272%
Share-based Payment Arrangement, Expense 100K USD +1900%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%